Palisade Bio, Inc.

PALI · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$2,868-$2,784-$2,230-$3,344
Dep. & Amort.$1$1$1$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$69$69$0
Change in WC-$1,069$799-$203$741
Other Non-Cash$383$98$30$222
Operating Cash Flow-$3,553-$1,817-$2,333-$2,381
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0$0$0
Financing Activities
Debt Repay.-$100$0-$80-$156
Stock Issued$3,908$4-$178$4,318
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$445$0$0$0
Financing Cash Flow$3,363$4-$258$4,162
Forex Effect$0$0$0$0
Net Chg. in Cash-$190-$1,813-$2,591$1,781
Supplemental Information
Beg. Cash$5,417$7,256$9,847$8,040
End Cash$5,227$5,443$7,256$9,821
Free Cash Flow-$3,553-$1,817-$2,333-$2,381
Palisade Bio, Inc. (PALI) Financial Statements & Key Stats | AlphaPilot